Global Spot Vision Screener Market- Key Developments
On February 13 2023, Gaize, Inc., an automated testing device for discovering and capturing evidence of impairment announced the launch of its real-time impairment screening device. The product is a first-of-its-kind fully automated, non-invasive and portable eye movement test. It combines well-established Drug Recognition Expert (DRE) eye examinations.
On March 13, 2023, Visionix, a global manufacturer of ophthalmic diagnostic devices, announced a new multimodal device update with its second-generation VX 650. VX 650 is an advanced anterior segment analyzer with retinal imaging. The enhanced wavefront-based aberrometer's "quick mode" and new capture flexibilities can decrease screening time by half, offering improved product efficiency.
In November 2022, AEYE Health, a digital health company that provides fully autonomous, Artificial Intelligence (AI)-based diagnostic screening solutions for retinal imaging received 510(k) clearance for a system that uses artificial intelligence to diagnose diabetic retinopathy from retinal images which can cause spot vision. The U.S Food and Drug Administration (FDA) clearance positions AEYE Health to sell a technology that achieved 93% sensitivity and 91.4% specificity in a clinical trial.
In September 2022, India Vision Institute (IVI), an India-based nongovernmental organization working to provide access to underprivileged vision screening and a pair of free spectacles to those in need, has won the Vision2020 Dr. Jordan Kassalow Vision Spring Award.
Spot Vision Screener Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients